Subsequent experiments revealed significantly increased miR-372 level after siRNA-mediated inhibition of HULC, indicating that HULC decreases miR-372 expression in HCC and enhances chromatin accessibility and transcription. The gene discussed is HULC; the disease is hepatocellular carcinoma.